Skip to Main Content

Paper Details

Diversity-oriented synthesis yields a new drug lead for treatment of chagas disease.
ACS Med Chem Lett
32
2013
Chagas disease, Trypanosoma cruzi, chagas disease, exocyclic primary alcohol, halobenzyl, isonicotinamide, p-phenoxy benzyl, secondary amine
Author NameAffiliation
Leigh C CarmodyCenter for the Science of Therapeutics, Broad Institute of MIT and Harvard
Leigh C CarmodyCenter for the Science of Therapeutics, Broad Institute of MIT and Harvard
James H McKerrowCenter for Discovery and Innovation in Parasitic Diseases, University of California San Francisco
Stuart L SchreiberCenter for the Science of Therapeutics, Broad Institute of MIT and Harvard , United States Howard Hughes Medical Institute, Harvard University
Stuart L SchreiberCenter for the Science of Therapeutics, Broad Institute of MIT and Harvard , United States Howard Hughes Medical Institute, Harvard University
  • 1 - 5

Datasets